about
Immunohistochemical detection of alpha1E voltage-gated Ca(2+) channel isoforms in cerebellum, INS-1 cells, and neuroendocrine cells of the digestive system.Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancerGastric cancers of Western European and African patients show different patterns of genomic instability.The proportion of tumour cells is an independent predictor for survival in colorectal cancer patientsCommon variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus.Comprehensive mutation analysis in colorectal flat adenomasThe septin-binding protein anillin is overexpressed in diverse human tumors.Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas.NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.Technical reproducibility of single-nucleotide and size-based DNA biomarker assessment using DNA extracted from formalin-fixed, paraffin-embedded tissues.RandomSpot: A web-based tool for systematic random sampling of virtual slides.Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer.A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets.Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease.Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancerAnnexin A1 sustains tumor metabolism and cellular proliferation upon stable loss of HIF1A.Genetic and structural variation in the gastric cancer kinome revealed through targeted deep sequencingHigh resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers.Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma.NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma.Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trialConsensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.Guidelines and considerations for conducting experiments using tissue microarrays.Gastric cancer pathology and underlying molecular mechanisms.Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer.Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer.KRAS and BRAF mutations in Nigerian colorectal cancers.Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial.MRI for Local Staging of Colon Cancer: Can MRI Become the Optimal Staging Modality for Patients With Colon Cancer?Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives.Erratum to: Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future.Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future.Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene.Immunodetection of alpha1E voltage-gated Ca(2+) channel in chromogranin-positive muscle cells of rat heart, and in distal tubules of human kidney.New isoform of the neuronal Ca2+ channel alpha1E subunit in islets of Langerhans and kidney--distribution of voltage-gated Ca2+ channel alpha1 subunits in cell lines and tissues.Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial.The survival difference between gastric cancer patients from the UK and Japan remains after weighted propensity score analysis considering all background factors.Q-FISH analysis of telomere and chromosome instability in the oesophagus with and without squamous cell carcinoma in situ.A multidisciplinary approach to management of autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED).Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer.
P50
Q27863655-9D7ECEAE-F952-4C6D-88F5-0E694F1D5B89Q28265268-1A0839A3-4E2B-4490-89E2-12DD48A591BEQ33791441-245FD8F1-6885-4805-B2F2-EAE09709C059Q33847884-290FE137-EBD5-4915-A443-80A3376B3C9AQ34298428-DD063211-BB90-4574-AEF6-C2C19B7153B4Q34359322-44657CCB-47D0-41B8-A89B-2753444038CEQ34456617-1141608F-1761-4E36-AD78-9424C2599ED1Q35071360-9DABC3E0-61A1-4BF9-8962-7A4B6BF9EFFDQ35085650-0FFFC8D7-2E11-4586-873A-993E5D0AD955Q35543090-96EA4F2B-83F9-4F3C-BB43-8B3208E6FC09Q35577890-9086AE85-B1CE-4DD3-B1FF-B69E2CF053E8Q35817821-72C59E81-74EE-49B0-8E2B-CB213AD193B2Q35878807-4F5271EF-035B-4AFE-8F0B-DBCE8264E3E4Q36083468-B8AF1A52-023B-4FCC-9ACF-96BF9447461BQ36778082-9AF418A1-5BFF-4DF9-85D4-D0452AC3D31EQ36916313-283E696B-B4D5-4AA8-80DC-23017F501142Q37035434-FB59D2B9-BB02-4A5A-9A73-7B70464C80E0Q37348746-2D7460D1-7168-46E1-8EC4-F627BAD149C7Q37536791-A447FC32-2AE1-4660-8388-A4DEA2FFA43FQ37686867-F253B5A8-591C-43BA-AF8F-7B2E48215A10Q37718402-395C9AEF-7A69-4C72-92CC-9A25C113C89DQ38005810-3CE3E426-5483-413B-A6BF-E14FC7D0C3BEQ38106730-73BBE9ED-A38F-4B9A-B2A8-46024A28B022Q38122579-C7F0B5A5-BBF2-4B17-A0E9-0C9E34A90FA6Q38290004-24984E86-B41C-4F7D-B1FF-AC2AAC3747C6Q38326633-DC5A03E8-4994-4649-8AC4-8ED02B92D7C6Q38398541-C924DEB9-9414-4809-B0A9-6B40E2407AACQ38636439-26696A04-524C-45FE-BF99-FBE1A54F7870Q38749709-BC4CCBC2-186C-430F-A5DB-34A6120FFA7DQ38796593-29769EC8-C7F4-4745-A5BD-5F30921E2DB5Q38806088-FA833C5D-0A72-46DC-A7B4-208EB3634397Q38826581-38AE0E91-DB47-4F41-99E2-CCCF0ADFBC63Q39976259-C94E47D2-B5F5-44E4-9C3F-F06DFEA0DBE2Q40878635-8C946D48-DA6C-481A-8A0E-B923F5A0A922Q40997602-902F9770-78E3-4766-9B42-84FD26E71515Q41069109-CFE99407-172C-44EC-8D0C-D65FC1A2ACD1Q41242836-D27EB7C2-E013-4537-8DBA-319F18765E14Q42471233-602286A9-31C6-44BC-A174-29AE72CFBF1EQ43221986-D16D0AC9-D43A-48D1-AA52-74506B512C92Q44283662-956465B0-85A5-48F2-9D3A-6697044B8625
P50
description
hulumtues
@sq
researcher
@en
researcher
@en-ca
researcher
@en-gb
wetenschapper
@nl
ymchwilydd
@cy
հետազոտող
@hy
name
Heike Irmgard Grabsch
@ast
Heike Irmgard Grabsch
@cy
Heike Irmgard Grabsch
@de
Heike Irmgard Grabsch
@en
Heike Irmgard Grabsch
@en-ca
Heike Irmgard Grabsch
@en-gb
Heike Irmgard Grabsch
@es
Heike Irmgard Grabsch
@fr
Heike Irmgard Grabsch
@it
Heike Irmgard Grabsch
@nl
type
label
Heike Irmgard Grabsch
@ast
Heike Irmgard Grabsch
@cy
Heike Irmgard Grabsch
@de
Heike Irmgard Grabsch
@en
Heike Irmgard Grabsch
@en-ca
Heike Irmgard Grabsch
@en-gb
Heike Irmgard Grabsch
@es
Heike Irmgard Grabsch
@fr
Heike Irmgard Grabsch
@it
Heike Irmgard Grabsch
@nl
altLabel
Heike Grabsch
@cy
Heike Grabsch
@en
Heike Grabsch
@en-gb
Heike Irmgard Grabsch
@cy
Heike Irmgard Grabsch
@en
Heike Irmgard Grabsch
@en-gb
prefLabel
Heike Irmgard Grabsch
@ast
Heike Irmgard Grabsch
@cy
Heike Irmgard Grabsch
@de
Heike Irmgard Grabsch
@en
Heike Irmgard Grabsch
@en-ca
Heike Irmgard Grabsch
@en-gb
Heike Irmgard Grabsch
@es
Heike Irmgard Grabsch
@fr
Heike Irmgard Grabsch
@it
Heike Irmgard Grabsch
@nl
P106
P1153
6602510654
P2031
2000-01-01T00:00:00Z
P21
P213
0000 0001 2444 5694
P31
P496
0000-0001-9520-6228